Rare diseases
Investigational molecules
Locations
Back to Poland113 clinical trials in Koszalin, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.
PolandA Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss
PolandStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
PolandStudy of Lorigerlimab and Docetaxel for Patients with Metastatic Castration-Resistant Prostate Cancer
PolandStudy of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
PolandStudy on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy
PolandStudy of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer
PolandEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PolandEvaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study
PolandPhase 3 Study of Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Metastatic NSCLC with PD-L1 TPS ≥50%
PolandA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
PolandStudy of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on bladder cancer and prostate cancer treatments, including combination therapies with immunological agents and targeted treatments.
Studies evaluating durvalumab, BCG combinations, and hormone therapy approaches for improved patient outcomes.
Advanced studies in gastric cancer and gastroesophageal junction cancers, focusing on targeted therapies and immunotherapy combinations.
Investigating trastuzumab deruxtecan and other innovative treatment combinations for metastatic disease.
Comprehensive research in non-small cell lung cancer, exploring novel drug combinations and immunotherapy approaches.
Evaluating new therapeutic options including pembrolizumab combinations and investigational agents.
Pioneering research in advanced breast cancer treatment, particularly focusing on hormone receptor-positive, HER2-negative disease.
Studies exploring new treatment combinations with CDK4/6 inhibitors and hormone therapy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
